Results 151 to 160 of about 444,660 (199)

Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis. [PDF]

Open Heart
Collini V, Andreis A, De Biasio M, De Martino M, Isola M, Croatto N, Lepre V, Cantarini L, Merlo M, Sinagra G, Abbate A, Lazaros G, Brucato A, Klein AL, Imazio M.   +14 more
europepmc   +1 more source

[Acute recurrent pericarditis].

Revista medica de Chile, 1998
J, AHUMADA, L, NIEDMANN, A, ILLANES
openaire   +1 more source

Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease. [PDF]

J Clin Med
Casarin F, Mascolo R, Motta I, Wu MA, Bizzi E, Pedroli A, Dieguez G, Iacomelli G, Serati L, Duca L, Maestroni S, Tombetti E, Cappellini MD, Brucato A.   +13 more
europepmc   +1 more source

Lessons From Genetics About the Interleukin 1 Gene and Treatment of Recurrent Pericarditis. [PDF]

JAMA Cardiol
Weber B, Honigberg MC.
europepmc   +1 more source

Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti-Interleukin-1 Agents. [PDF]

ACR Open Rheumatol
Ceriani E, Agozzino F, Berra S, Gidaro A, Bindi P, Pavarani A, Macchi S, Vena L, Moda F, Sicignano LL, Murace CA, Gerardino L, Verrecchia E, De Carlini CC, Maestroni S, Marinaro G, Bizzi E, Brucato A, Imazio M.   +18 more
europepmc   +1 more source

Treatment of recurrent pericarditis

Expert Review of Cardiovascular Therapy, 2012
Recurrent pericarditis is the most common and troublesome complication of pericarditis affecting around a third of patients. Treatment of this condition is often one of the most challenging task in pericardial diseases management, especially in corticosteroids-dependent cases.
Massimo Imazio
exaly   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Recurrent Pericarditis

Progress in Cardiovascular Diseases, 2017
Recurrent pericarditis is the most troublesome complication of pericarditis occurring in 15 to 30% of cases. The pathogenesis is often presumed to be immune-mediated although a specific rheumatologic diagnosis is commonly difficult to find. The clinical diagnosis is based on recurrent pericarditis chest pain and additional objective evidence of disease
Massimo Imazio
exaly   +7 more sources

Rilonacept for the treatment of recurrent pericarditis

Expert Opinion on Biological Therapy, 2022
Recurrent pericarditis (RP) is a debilitating disease that has an underlying autoinflammatory pathophysiology mediated by cytokine interleukin (IL)-1. Rilonacept, a recombinant dimeric fusion protein that blocks IL-1α and IL-1β signaling has emerged as a valuable therapeutic option of RP.
Reza Reyaldeen, Emmanuel Akintoye
exaly   +3 more sources

Colchicine for the prevention of recurrent pericarditis.

The Israel Medical Association journal : IMAJ, 2008
The most troublesome complication of acute pericarditis is recurrent episodes of pericardial inflammation, which occur in 15-32% of cases. It was recently found that viral infection has a major role, but in many cases the cause is unknown. The optimal method for prevention has not been fully established; accepted modalities include non-steroidal anti ...
Markel G, Imazio M, Brucato A, Adler Y
core   +6 more sources